Grace Therapeutics, Inc.

Grace Therapeutics, Inc.verified

GRCE

Price:

$3.28

Market Cap:

$46.36M

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey.

Industry

Biotechnology

IPO Date

2012-02-07

Stock Exchange

NASDAQ

Ticker

GRCE

The Dividend Yield as of December 2025 (TTM) for Grace Therapeutics, Inc. (GRCE) is 0%

According to Grace Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Grace Therapeutics, Inc. (GRCE) Historical Dividend Yield (quarterly & annually)

How has GRCE Dividend Yield performed in the past?

The mean historical Dividend Yield of Grace Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), GRCE's Dividend Yield was at its highest in in the August 2015 quarter at 0%. The Dividend Yield was at its lowest in in the August 2015 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Grace Therapeutics, Inc. (GRCE) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Grace Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20250%0%
20240%0%
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20160%0%
20150%0%

Grace Therapeutics, Inc. (GRCE) Average Dividend Yield

How has GRCE Dividend Yield performed in the past?

The current Dividend Yield of Grace Therapeutics, Inc. (GRCE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Grace Therapeutics, Inc. (GRCE) Dividend Yield vs. Peers

How is GRCE’s Dividend Yield compared to its peers?

Grace Therapeutics, Inc.’s Dividend Yield is less than LAVA Therapeutics N.V. (0%), less than Tvardi Therapeutics, Inc. (0%), less than Actinium Pharmaceuticals, Inc. (0%), less than PDS Biotechnology Corporation (0%), less than CalciMedica, Inc. (0%), less than Xilio Therapeutics, Inc. (0%), less than Lantern Pharma Inc. (0%), less than OnKure Therapeutics, Inc. (0%), less than RenovoRx, Inc. (0%), less than ABVC BioPharma, Inc. (0%),

Build a custom stock screener for Grace Therapeutics, Inc. (GRCE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Grace Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Grace Therapeutics, Inc. (GRCE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Grace Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Grace Therapeutics, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Grace Therapeutics, Inc. (GRCE)?

What is the highest Dividend Yield for Grace Therapeutics, Inc. (GRCE)?

What is the 3-year average Dividend Yield for Grace Therapeutics, Inc. (GRCE)?

What is the 5-year average Dividend Yield for Grace Therapeutics, Inc. (GRCE)?

How does the current Dividend Yield for Grace Therapeutics, Inc. (GRCE) compare to its historical average?